QT Ultrasound, based in Novato, United States, is dedicated to advancing breast health diagnostics through innovative imaging technology. The company’s core mission is to provide non-invasive, highly accurate diagnostic tools that enhance the assessment of breast tissue. Their flagship product, the Breast Acoustic CT™ Scanner, utilizes low-frequency sound waves and true 3D acquisition to deliver comprehensive imaging. This FDA-cleared device offers a complementary diagnostic option to traditional methods, aiding radiologists in making more informed decisions about breast health.
QT Ultrasound has garnered significant support and recognition, including grants from the National Cancer Institute, part of the National Institutes of Health (NIH), to further develop their technology and conduct clinical trials. The company’s achievements include obtaining FDA 510(k) clearance for their Breast Acoustic CT™ Scanner. With these advancements, QT Ultrasound is making a substantial impact on the field of breast imaging, providing a safer and more detailed alternative to existing diagnostic methods.
